Completed
This inquiry was completed in the 56th parliament.
For more information on this inquiry, contact the Committees office:
Phone: (03) 8682 2800
Email: cso@parliament.vic.gov.au
For more information on this inquiry, contact the Committees office:
Phone: (03) 8682 2800
Email: cso@parliament.vic.gov.au
Received from the Legislative Assembly on 1st March 2007 under section 33 of the Parliamentary Committees Act 2003.
To the Drugs and Crime Prevention Committee – for inquiry, consideration and report no later than 30 November 2007 on the misuse/abuse of benzodiazepines and other forms of pharmaceutical drugs in Victoria with particular regard to:
1. Examine the nature, extent and culture of the misuse/abuse of benzodiazepines and other forms of pharmaceutical drugs;
2. Examine the short and long term consequences/harms of the abuse/misuse of benzodiazepines and other forms of pharmaceutical drugs;
3. Examine the relationship between benzodiazepines and other forms of pharmaceutical drugs and other forms of licit and illicit substance use;
4. Review the adequacy of existing strategies for dealing with benzodiazepines and other forms of pharmaceutical drugs misuse/abuse;
5. Recommend best practice strategies to address the issue of benzodiazepines and other forms of pharmaceutical drugs, including regulatory, law enforcement, education and treatment responses; and
6. Examine national and international legislation, reports and materials relevant to the issue.
To the Drugs and Crime Prevention Committee – for inquiry, consideration and report no later than 30 November 2007 on the misuse/abuse of benzodiazepines and other forms of pharmaceutical drugs in Victoria with particular regard to:
1. Examine the nature, extent and culture of the misuse/abuse of benzodiazepines and other forms of pharmaceutical drugs;
2. Examine the short and long term consequences/harms of the abuse/misuse of benzodiazepines and other forms of pharmaceutical drugs;
3. Examine the relationship between benzodiazepines and other forms of pharmaceutical drugs and other forms of licit and illicit substance use;
4. Review the adequacy of existing strategies for dealing with benzodiazepines and other forms of pharmaceutical drugs misuse/abuse;
5. Recommend best practice strategies to address the issue of benzodiazepines and other forms of pharmaceutical drugs, including regulatory, law enforcement, education and treatment responses; and
6. Examine national and international legislation, reports and materials relevant to the issue.